Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
119 tokens/sec
GPT-4o
56 tokens/sec
Gemini 2.5 Pro Pro
43 tokens/sec
o3 Pro
6 tokens/sec
GPT-4.1 Pro
47 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Risk markers by sex for in-hospital mortality in patients with acute coronary syndrome: a machine learning approach (2101.01835v3)

Published 6 Jan 2021 in cs.LG and stat.AP

Abstract: Background: Several studies have highlighted the importance of considering sex differences in the diagnosis and treatment of Acute Coronary Syndrome (ACS). However, the identification of sex-specific risk markers in ACS sub-populations has been scarcely studied. The present study aims to explore ML models to identify in-hospital mortality markers for women and men in ACS sub-populations collected from a public database of electronic health records (EHR). Methods: We extracted 1,299 patients with ST-elevation myocardial infarction (STEMI) and 2,820 patients with non-ST-elevation myocardial infarction (NSTEMI) from the Medical Information Mart for Intensive Care (MIMIC)-III database. We trained and validated mortality prediction models and used an interpretability technique to identify sex-specific markers for each sub-population. Results: The models based on eXtreme Gradient Boosting (XGBoost) achieved the highest performance: area under the curve (AUC) = 0.94 (95\% CI:0.84-0.96) for STEMI and AUC = 0.94 (95\% CI:0.80-0.90) for NSTEMI. For STEMI, the top markers in women are chronic kidney failure, high heart rate, and age over 70 years. For men, the top markers are acute kidney failure, high troponin T levels, and age over 75 years. However, for NSTEMI, the top markers in women are low troponin levels, high urea levels, and age over 80 years. For men, the top markers are high heart rate, creatinine levels, and age over 70 years. Conclusions: Our results show possible significant and coherent sex-specific risk markers of different ACS sub-populations by interpreting ML mortality models trained on EHRs. Differences are observed in the identified risk markers between women and men, highlighting the importance of considering sex-specific markers in implementing more appropriate treatment strategies and better clinical outcomes.

User Edit Pencil Streamline Icon: https://streamlinehq.com
Authors (5)
  1. Blanca Vazquez (1 paper)
  2. Gibran Fuentes-Pineda (9 papers)
  3. Fabian Garcia (1 paper)
  4. Gabriela Borrayo (1 paper)
  5. Juan Prohias (1 paper)
Citations (4)

Summary

We haven't generated a summary for this paper yet.